Eric Venker
CIK 1801917 · President & Immunovant CEO · last filed 2026-07-29
Eric Venker is a President & Immunovant CEO who has filed 165 SEC Form 4 insider transactions across 3 companies since 2022. The most recent filing, for ROIV, was dated Jul 29, 2026. Across all open-market trades the lifetime net is −$193.7M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $79.2M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$79.16M
3
165
-$193.75M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ROIV | President & Immunovant CEO | 1,813,063 | $37.37 | $67.75M | -$169.92M | 50 | 2026-07-29 |
| IMVT | Chief Executive Officer | 257,372 | $44.30 | $11.40M | -$461.8K | 4 | 2026-07-06 |
| Roivant Sciences Ltd. (ROIVW) Delisted | President & COO | 611,813 | $2.75 | $1.68M | -$23.37M | 32 | 2023-08-24 |
Recent Filings
165 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-07-29 | ROIV | Mixed | — | -$6.22M | EDGAR |
| 2026-07-27 | ROIV | Notice (144) | −200,000 | -$6.99M | EDGAR |
| 2026-07-06 | IMVT | Mixed | +2,467 | -$2.09M | EDGAR |
| 2026-06-26 | ROIV | Mixed | — | -$5.86M | EDGAR |
| 2026-06-24 | ROIV | Notice (144) | −200,000 | -$6.63M | EDGAR |
| 2026-05-22 | ROIV | Notice (144) | −200,000 | -$6.05M | EDGAR |
| 2026-05-22 | ROIV | Mixed | −34,483 | -$6.40M | EDGAR |
| 2026-04-22 | ROIV | Mixed | — | -$5.15M | EDGAR |
| 2026-04-20 | ROIV | Notice (144) | −200,000 | -$5.92M | EDGAR |
| 2026-04-09 | IMVT | Grant (A) | +232,252 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.